Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active-Controlled Trial of the Safety and Tolerability of a MP03-33 in Patients With Chronic Allergic or Nonallergic Rhinitis

NCT00783432 is registered in ClinicalTrials.gov with Meda Pharmaceuticals as lead sponsor.

NCT NCT00783432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00783432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active-Controlled Trial of the Safety and Tolerability of a MP03-33 in Patients With Chronic Allergic or Nonallergic Rhinitis
Lead sponsor
Meda Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2006
Completion date
December 31, 2007
Enrollment
862 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic allergic rhinitis, nonallergic rhinitis